ArticleJournal for immunotherapy of cancer2021

Combining CTLA-4 and angiopoietin-2 blockade in patients with advanced melanoma: a phase I trial.

Patrick A Ott et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.